Constant van Boeckel

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (152)

• A natural-product switch for a dynamic protein interface
  Angew. Chem Int Ed Engl 2014 DOI: 10.1002/anie.201403773 [doi]
  +Save
• Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors
  J Med Chem 2014 DOI: 10.1021/jm501181z [doi]
  +Save
• Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index
  PLoS One 2012 DOI: 10.1371/journal.pone.0048385 [doi];PONE-D-12-11617 [pii]
  +Save
• From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile
  Thromb Haemost 2009 DOI: 09-01-0063 [pii];10.1160/TH09-01-0063 [doi]
  +Save
• The state of the art of chemical biology
  Chembiochem 2009 DOI: 10.1002/cbic.200800758 [doi]
  +Save
• Conjugation of ATIII-binding pentasaccharides to extend the half-life of proteins: long-acting insulin
  ChemMedChem 2008 DOI: 10.1002/cmdc.200800053 [doi]
  +Save
• A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy
  J Am Chem Soc 2005 DOI: 10.1021/ja045613g [doi]
  +Save
• Medicinal chemistry education: What is needed and where is it going?
  Drug Development Research 2005
  +Save
• Synthetic heparin derivatives as new anticoagulant drugs
  Drug Discov Today 2005 DOI: S1359-6446(05)03457-4 [pii];10.1016/S1359-6446(05)03457-4 [doi]
  +Save
• A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
  Angew. Chem Int Ed Engl 2004 DOI: 10.1002/anie.200300640 [doi]
  +Save